Medicxi Ventures Management (Jersey) Ltd

Est. AUM

$981.8M

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	CENTESSA PHARMACEUTICALS PLC	SPONSORED ADS	$792.9M	19963157	80.76%	SOLE
2	NEWAMSTERDAM PHARMA COMPANY	ORDINARY SHARES	$85.6M	2674182	8.72%	SOLE
3	PHATHOM PHARMACEUTICALS INC	COM	$82.9M	7464572	8.45%	SOLE
4	AURA BIOSCIENCES INC	COM	$20.3M	3039892	2.07%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.